Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,893,625 papers from all fields of science
Search
Sign In
Create Free Account
quelamycin
Known as:
triferric doxorubicin
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
Doxorubicin
Narrower (1)
NSC-267703
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Iron Supplementation: What's New?
I. Macdougall
2017
Corpus ID: 80907795
Supplemental orally-administered iron has been available for centuries, but parenteral administration of iron as a therapeutic…
Expand
2012
2012
Abstract 4611: Cancer reversal by dual strategy: A new molecular target?
M. Gosálvez
2012
Corpus ID: 58262854
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Haste is a bad counselor when one is striving to…
Expand
1981
1981
Neurotoxicity of quelamycin in the rat.
Jortner Bs
,
Cho Es
1981
Corpus ID: 88698290
: Male Sprague-Dawley rats were given a single dose of 10 or 20 mg/kg quelamycin intravenously and perfusion fixed at 4, 12, 28…
Expand
1981
1981
Neurotoxicity of quelamycin in the rat.
B. S. Jortner
,
E. Cho
Neurotoxicology
1981
Corpus ID: 5768729
Male Sprague-Dawley rats were given a single dose of 10 or 20 mg/kg quelamycin intravenously and perfusion fixed at 4, 12, 28 and…
Expand
1980
1980
Quelamycin: a summary of phase I clinical trials.
H. Cortés-Funes
,
A. Brugarolas
,
M. Gosálvez
Recent results in cancer research. Fortschritte…
1980
Corpus ID: 10573421
Quelamycin is triferric doxorubicin, a metallic derivative of adriamycin which, in experimental studies, has been found to have a…
Expand
1979
1979
Early clinical trial with quelamycin.
H. Cortés-Funes
,
M. Gosálvez
,
A. Moyano
,
A. Mañas
,
C. Mendiola
Cancer treatment reports
1979
Corpus ID: 7609599
Quelamycin (triferric doxorubicin) is a derivative of Adriamycin with different pharmacologic properties. Our phase I clinical…
Expand
1979
1979
Iron toxicity studies of quelamycin.
A. Brugarolas
,
J. P. Pérez Llanderal
,
+5 authors
A. Ribas
Cancer treatment reports
1979
Corpus ID: 23489318
A previous phase I study demonstrated excessive generalized toxicity (20 of 21 patients) and cardiotoxicity (eight of 21 patients…
Expand
Highly Cited
1978
Highly Cited
1978
Quelamycin, a new derivative of adriamycin with several possible therapeutic advantages.
M. Gosálvez
,
M. Blanco
,
C. Vivero
,
F. Valles
European Journal of Cancer
1978
Corpus ID: 27464746
1978
1978
Phase I clinical study of quelamycin.
A. Brugarolas
,
N. Pachón
,
+4 authors
M. Marco
Cancer treatment reports
1978
Corpus ID: 19559590
A phase I clinical study was done with quelamycin, a recently synthesized triferric derivative of adriamycin. Twenty-one good…
Expand
1978
1978
Preliminary evaluation of a phase I clinical study of quelamycin.
H. Cortes
,
J. Vicente
,
L. Baena
,
J. Otero
,
M. Gosálvez
European Journal of Cancer
1978
Corpus ID: 44486570
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE